Follow the Lotus Eye Hospital and Institute Limited share price and the full directors' dealings record of the company, a listed issuer based in India. Shares are listed on the IN market, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Lotus Eye Hospital and Institute Limited has recorded 8 public disclosures. Market capitalisation: €2.4bn. The latest transaction was filed on 6 July 2024 (Sale). Among the most active insiders: S Rajkumar. All data is accessible without an account.
8
Insider Decl.
n/a
Thresholds
€40,170
2 ops.
Buy Volume
€2m
4 ops.
Sell Volume
8Σ signal
Buys €40,170€2m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,043 of 29,062 companies
28.6
score / 100
Value
19
Quality
38
FCF yld-4.1%
Earn yld0.0%
EV/EBITDA57.1x
ROE0.1%
Gross mgn49%
Net mgn0.1%
Debt/EBITDA3.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
3,682,307 shares@ ₹8.554412.6% of flowEquity SharesSEBI:33d0805e0063faceceddcf221aac87a54ee455e9
8 of 8 declarations
About Lotus Eye Hospital and Institute Limited
Lotus Eye Hospital and Institute Limited is a healthcare facility specializing in eye care in India. It provides a range of services from consultations to surgical interventions.